Metabolic reprogramming of the tumor microenvironment by p62 and its partners.

TitleMetabolic reprogramming of the tumor microenvironment by p62 and its partners.
Publication TypeJournal Article
Year of Publication2018
AuthorsReina-Campos M, Shelton PM, Diaz-Meco MT, Moscat J
JournalBiochim Biophys Acta Rev Cancer
Volume1870
Issue1
Pagination88-95
Date Published2018 08
ISSN1879-2561
KeywordsHumans, Neoplasms, Sequestosome-1 Protein, Tumor Microenvironment
Abstract

The concerted metabolic reprogramming across cancer and normal cellular compartments of the tumor microenvironment can favor tumorigenesis by increasing the survival and proliferating capacities of transformed cells. p62 has emerged as a critical signaling adaptor, beyond its role in autophagy, by playing an intricate context-dependent role in metabolic reprogramming of the cell types of the tumor and stroma, which shapes the tumor microenvironment to control tumor progression. Focusing on metabolic adaptations, we review the cellular processes upstream and downstream of p62 that regulate how distinct cell types adapt to the challenging and evolving environmental conditions during tumor initiation and progression. In addition, we describe partners of p62 that, in a collaborative or independent manner, can also rewire cell metabolism. Finally, we discuss the potential therapeutic implications of targeting p62 in cancer, considering its multifaceted roles in diverse cell types of the tumor microenvironment.

DOI10.1016/j.bbcan.2018.04.010
Alternate JournalBiochim Biophys Acta Rev Cancer
PubMed ID29702207
PubMed Central IDPMC6193563
Grant ListR01 DK108743 / DK / NIDDK NIH HHS / United States
R01 CA192642 / CA / NCI NIH HHS / United States
R01 CA218254 / CA / NCI NIH HHS / United States
R01 CA172025 / CA / NCI NIH HHS / United States
R01 CA211794 / CA / NCI NIH HHS / United States
R01 CA207177 / CA / NCI NIH HHS / United States
Related Faculty: 
Maria Diaz-Meco Conde, Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700